STNN-DDI: a Substructure-aware Tensor Neural Network to predict Drug-Drug Interactions

被引:32
作者
Yu, Hui [1 ]
Zhao, ShiYu [1 ]
Shi, JianYu [2 ]
机构
[1] Northwestern Polytech Univ, Sch Comp Sci, Xian 710072, Peoples R China
[2] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Peoples R China
关键词
Tensor Neural Network; drug-drug interactions; substructure-substructure interactions; multi-type interactions;
D O I
10.1093/bib/bbac209
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Computational prediction of multiple-type drug-drug interaction (DDI) helps reduce unexpected side effects in poly-drug treatments. Although existing computational approaches achieve inspiring results, they ignore to study which local structures of drugs cause DDIs, and their interpretability is still weak. In this paper, by supposing that the interactions between two given drugs are caused by their local chemical structures (substructures) and their DDI types are determined by the linkages between different substructure sets, we design a novel Substructure-aware Tensor Neural Network model for DDI prediction (STNN-DDI). The proposed model learns a 3-D tensor of < substructure, substructure, interaction type > triplets, which characterizes a substructure-substructure interaction (SSI) space. According to a list of predefined substructures with specific chemical meanings, the mapping of drugs into this SSI space enables STNN-DDI to perform the multiple-type DDI prediction in both transductive and inductive scenarios in a unified form with an explicable manner. The comparison with deep learning-based state-of-the-art baselines demonstrates the superiority of STNN-DDI with the significant improvement of AUC, AUPR, Accuracy and Precision. More importantly, case studies illustrate its interpretability by both revealing an important substructure pair across drugs regarding a DDI type of interest and uncovering interaction type-specific substructure pairs in a given DDI. In summary, STNN-DDI provides an effective approach to predicting DDIs as well as explaining the interaction mechanisms among drugs. Source code is freely available at https://github.com/zsy-9/STNN-DDI.
引用
收藏
页数:12
相关论文
共 38 条
[1]  
Acar E., 2011, MLG 11 P MINING LEAR
[2]  
Arachchige PCM., 2021, COMPUT BIOL MED, V133
[3]  
Chu X, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4518
[4]   A multimodal deep learning framework for predicting drug-drug interaction events [J].
Deng, Yifan ;
Xu, Xinran ;
Qiu, Yang ;
Xia, Jingbo ;
Zhang, Wen ;
Liu, Shichao .
BIOINFORMATICS, 2020, 36 (15) :4316-4322
[5]   Computational prediction of drug-drug interactions based on drugs functional similarities [J].
Ferdousi, Reza ;
Safdari, Reza ;
Omidi, Yadollah .
JOURNAL OF BIOMEDICAL INFORMATICS, 2017, 70 :54-64
[6]  
Fu TF, 2020, AAAI CONF ARTIF INTE, V34, P638
[7]   SIMULTANEOUS MODELING OF PHARMACOKINETICS AND PHARMACODYNAMICS WITH A NONPARAMETRIC PHARMACODYNAMIC MODEL [J].
FUSEAU, E ;
SHEINER, LB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :733-741
[8]   When good drugs go bad [J].
Giacomini, Kathleen M. ;
Krauss, Ronald M. ;
Roden, Dan M. ;
Eichelbaum, Michel ;
Hayden, Michael R. .
NATURE, 2007, 446 (7139) :975-977
[9]   INDI: a computational framework for inferring drug interactions and their associated recommendations [J].
Gottlieb, Assaf ;
Stein, Gideon Y. ;
Oron, Yoram ;
Ruppin, Eytan ;
Sharan, Roded .
MOLECULAR SYSTEMS BIOLOGY, 2012, 8
[10]   Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System [J].
Harpaz, R. ;
DuMouchel, W. ;
LePendu, P. ;
Bauer-Mehren, A. ;
Ryan, P. ;
Shah, N. H. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (06) :539-546